5q deletion
Xem 1-1 trên 1 kết quả 5q deletion
-
Lenalidomide has been approved for the treatment of lower-risk myelodysplastic syndrome (MDS) with 5q deletion (del(5q)). We present for the first time a retrospective analysis of low-risk MDS with isolated del5q treated with lenalidomide, outside the clinical trials.
6p viamsterdam 18-09-2020 10 1 Download
CHỦ ĐỀ BẠN MUỐN TÌM
TOP DOWNLOAD